AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2024
Feb 29, 2024
29755_dirs_2024-02-29_56789aef-39f1-4433-8153-44591d6cf68b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-02-27
Reporting Person: GONZALEZ RICHARD A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-27 | Common Stock, $0.01 par value | G | 1670 | — | Disposed | 770489 | Direct |
| 2024-02-27 | Common Stock, $0.01 par value | G | 2525 | — | Disposed | 767964 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4